Your Doctor Has Prescribed TYKERB Plus Xeloda®
You and your doctor have decided to treat your HER2+ (HER2-positive) advanced or metastatic breast cancer with TYKERB plus Xeloda. TYKERB plus Xeloda is indicated for patients whose tumors overexpress HER2 and who have had prior therapy with an anthracycline, a taxane, and Herceptin®. Get more from your treatment by learning as much as you can about it. Use this Web site to learn:
More for you and those who care for you
TYKERB.com is designed to provide you with the tools, information, and assistance you need to make the most of your treatment. For specific questions about breast cancer or treatment with TYKERB, visit Ask the Experts.
Talk to your healthcare provider about enrolling in the Tykerb® CARES support program. Tykerb® CARES offers tips for sticking with your treatment plan and assistance with researching insurance coverage and locating specialty pharmacies. Also, a full list of Internet links and downloadable materials are available in our patient resources section.
- Download Your Treatment With TYKERB, a brochure about what patients can expect while taking TYKERB.
- Download Tracking Your Treatment With TYKERB, an organizer to help you understand and stick with your treatment plan. A calendar is included to help you keep track of your dosing schedule.
To assist those who care for you, refer them to the information for caregivers page. They may also find the patient resources section helpful.
Check out GlaxoSmithKline's Tykerb® CARES support program to help patients and the healthcare providers who treat them.
Questions about treatment with TYKERB?
Ask the Experts
Get the latest information
from www.TYKERB.com
Indication
TYKERB is indicated in combination with Xeloda® (capecitabine) for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and Herceptin® (trastuzumab).
Important Safety Information
Before taking TYKERB, tell your doctor if you have heart problems. As with other treatments for HER2-positive advanced or metastatic breast cancer, there have been reports of changes in how the heart pumps blood through the body and how the heart beats. Call your doctor right away if you are short of breath, have rapid heartbeats (palpitations), or feel very tired.
Tell your doctor if you have liver problems. People who have liver problems may not be able to process TYKERB well, so you may need a lower dose of TYKERB.
Some people taking TYKERB have reported diarrhea. In some cases, diarrhea can be severe. Call your doctor right away if you have diarrhea. It is important to manage diarrhea with medicine as soon as it begins. Severe diarrhea may need to be treated with electrolytes and fluids given by mouth or by vein. Treatment with TYKERB may have to be delayed for a while or stopped completely.
If you have a dry cough or have shortness of breath, talk with your doctor. These may be signs of inflammation in the lungs.
Women should not become pregnant when taking TYKERB because the unborn baby may be harmed.
The most common side effects reported by patients taking TYKERB and Xeloda were diarrhea; vomiting; feeling sick to your stomach (nausea); feeling tired; red, painful hands and feet; and rash.
Tell your doctor about all the medicines you take, including prescription and nonprescription medicines and herbal and dietary supplements.
Because TYKERB is currently indicated to be taken with another medicine called Xeloda, be sure to talk with your doctor about any medicines and supplements that should be avoided when taking Xeloda.
Please see complete US Prescribing Information for TYKERB.
Herceptin is a registered trademark of Genentech, Inc.
Xeloda is a registered trademark of Roche Laboratories Inc.
Photos are for illustrative purposes only.